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Summary 
The accelerated autoimmune syndrome observed in BXSB/MpJ male mice is associated with 
the  presence  on  the  Y  chromosome of an  as yet  unidentified mutant gene,  designated Y 
chromosome-linked  autoimmune accderation (~a). To study the mechanisms by which the Yaa 
gene accelerates and/or induces the production of autoantibodies, we have developed double- 
congenic bone marrow chimeras containing B cells from autoimmune males carrying the Yaa 
gene, and from nonautoimmune  male or female mice lacking it and differing by the Igh allotype. 
The analysis of the allotype of total immunoglobulins and anti-DNA antibodies in ~a + male- 
normal female  (Yaa-)  chimeric mice revealed that  the  selective  activation  of B  ceils  from 
autoimmune  Yaa +  male  mice  was  responsible  for  the  hypergammaglobulinemia  and 
autoantibody production. This phenomenon was not due to an anti-HY interaction between 
female T  helper cells and male B cells, because first,  ~a + B cells were selectively stimulated 
to produce autoantibodies in ~a + male-Yaa-  male chimeric mice; and second, normal male 
and female chimeras failed to develop an autoimmune syndrome. In addition, the fact that both 
B cell populations in ~a +-~a-  chimeras similarly responded to a foreign antigen, human IgG, 
argues against the possibility that the selective activation of ~a + B cells may be due to their 
hyper-responsiveness to T helper signals. We propose that a cognate interaction of T helper cells 
with Yaa + B cells, because of possible T  cell recognition of a ~a-related molecule expressed 
on ~a + B cells, may be responsible for the acceleration and/or induction of autoantibodies in 
BXSB/MpJ mice. 
T 
he BXSB/MpJ (BXSB) strain spontaneously develops a 
progressive and lethal autoimmune disease, similar to 
human systemic lupus erythematosus, which affects male 
animals much earlier than females (1, 2). Cell transfer  and 
Y chromosome transfer studies have clearly demonstrated that 
the Y chromosome-linked autoimmune acceleration  (~a) 1 
gene present in the Y chromosome of the BXSB strain  is 
responsible for the accelerated autoimmune abnormalities and 
immunopathological  lesions in mice predisposed to autoim- 
mune diseases (3-6). However, the lack of induction of the 
autoimmune syndrome in Yaa gene-congenic normal mice 
(4, 5) indicates that the effect of this gene is dependent on 
the  presence  of  the  abnormal  autosomal  genome  in 
autoimmune-prone  mice. Although it has been demonstrated 
that CD4 + T  helper cells play an essential role in, the au- 
toantibody production and in development of fatal glomeru- 
lonephritis in male BXSB mice (7), the cellular and molec- 
ular mechanisms by which the Yaa gene abnormality promotes 
autoimmune  responses are poorly understood. In the present 
study, we have analyzed  whether a unique interaction be- 
tween T and B cells could result in autoantibody production 
in autoimmune mice bearing the Yaa gene. For this purpose, 
we have constructed radiation bone marrow chimeric mice 
consisting of autoimmune male cells carrying the Yaa gene, 
and of nonautoimmune male or female cells lacking the Yaa 
gene and differing by the Igh allotype, and determined the 
origin of B cells producing autoantibodies. Our results indi- 
cate that B cells from male mice bearing the Yaa gene are 
selectively activated to produce anti-DNA autoantibodies and 
hypergammaglobulinemia. 
1  Abbreviations used in this  paper: AHGG, aggregated human IgG; BMC, 
bone marrow cells; Yaa, Y chromosome-linked  autoimmune  acceleration. 
Materials and Methods 
Mice.  The C57BL/6 (B6, Igh  b) strain bearing the Yaa gene 
(B6.~a) was developed  in our laboratory by backcross procedures 
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Olac Ltd. (Oxon, UK). The B.C20/Icr (BC20) strain carrying the 
Igh" allotype on the B6 background was kindly provided by Dr. 
M. Bosma (Fox Chase Cancer Center, Philadelphia,  PA). The hy- 
brid mice used in this study were obtained as follows: B6.Yaa male 
mice carrying the Yaa gene and Igh  ab allotype, obtained by mating 
B6.Yaa males with BC20 females, were crossed with NZW females. 
The expression of the Igh allotype in these Pl hybrid mice was 
documented by an ELISA using polyclonal anti-Igh allotype anti- 
bodies as described below. It should be noted that like BXSB males, 
(NZW  x  B6.Yaa)P, male, but not female mice, spontaneously de- 
veloped a severe lupus-like syndrome (5). 
Preparation of  Bone Marrow Chimeras.  2-mo-old recipients were 
irradiated at 800 tad and reconstituted with bone marrow cells 
(BMC) from 6-7-too-old mice. A  mixture of 107 viable BMC 
were intravenously injected into irradiated recipients as detailed in 
Table 1. Chimeric mice were bled every 2 mo by retro-orbital sinus 
puncture, and resulting sera were stored at  -20~  until use. 
Antigens and Antibodies.  Calf thymus DNA (Sigma Chemical 
Co., St. Louis, MO) was heat-denatured and used as single-stranded 
DNA. Aggregated human IgG (AHGG) was prepared by heating 
HGG at 63~  for 30 min.  IgG fractions of goat anti-mouse 3/ 
chain-specific antibodies were purchased from Cappel Laborato- 
ries (CochranviUe, PA). Polyclonal anti-Igh' and anti-Igh  s aUotype 
antibodies were obtained in SJL mice immunized with BALB/c 
IgG and in BALB/c mice immunized against B6 IgG, respectively, 
as described previously (8). Anti-IgG2a  ~ (Ig[la]8.3) mAb reacting 
also with IgG2a of the Igh" allotype (9) and anti-IgG2a  b (C506FS) 
mAb were generously provided by Dr. L.A. Herzenberg (Stanford, 
CA) and Dr. J. Van Snick (Brussels, Belgium), respectively.  Poly- 
clonal antibodies and mAbs were purified with a protein A column 
and conjugated with alkaline phosphatase according to the proce- 
dure of Engvall and Perlmann (10). 
Immunization Protocol.  Yaa + male-Yaa-  female chimeric mice 
(group  I:  Table  1)  and  (NZW  x  B6)F1  males  were  in- 
traperitoneally injected and boosted 60 d  later with  500/~g of 
AHGG. Mice were bled 10 d after challenge. 
Serological Assays.  Serum levels of IgG were determined by 
ELISA as described (8).  Results are expressed in mg/ml in refer- 
ence to a standard curve obtained with mouse Ig reference serum 
(Miles  Scientific,  Naperville, IL). 
To determine serum levels of Igh" and Igh  b allotypes in sera, a 
previously described ELISA was used with alkaline phosphatase- 
conjugated anti-Igh' or anti-Igh  b allotype antibodies (8).  Results 
are expressed in titration units in reference to a serum pool from 
6-mo-old (B6  x  BC20)F1 (Igh  ~/b) mice.  Note that the anti-lgh  ' 
polyclonal antibodies used in the present study crossreact with the 
Igh" allotype, while anti-Igh  b antibodies do not react with the Igh' 
and Igh" (Fig.  1). 
Serum IgG2a  ~ and IgG2a  b levels were determined by ELISA. 
Microtiter plates  were coated with 5/~g/ml of Ig(la)8.3  (anti- 
IgG2a') or C506FS  (anti-IgG2a  b)  mAb.  After incubation with 
0.5%  BSA for 1 h at room temperature, serum samples diluted 
at 1:104 with 2% BSA in PBS containing 0.05% Tween 20 were 
added to the wells for an overnight incubation at 4~  Wells were 
then incubated with alkaline phosphatase-conjugated polyclonal anti- 
Igh  ~ antibody for the detection of IgG2a" or with C506FS (anti- 
IgG2a  b) mAb conjugates for the detection of IgG2aL Although 
both the Ig(la)8.3 mAb and anti-Igh  ' allotype polyclonal antibody 
are able to bind to IgG2a of the Igh" aUotype (IgG2ae), this ELISA 
method fails to detect IgG2a', most probably because the binding 
of IgG2a" to solid-phase anti-IgG2a"  mAb interferes with the rec- 
ognition of the IgG2a" epitope by anti-Igh  ~ antibodies (Fig.  1). 
Results are expressed  in mg/ml in reference to a standard curve 
obtained with purified IgG2a  a and IgG2a  b mAb. 
The activity of IgG anti-DNA antibodies in sera was measured 
by an ELISA as described previously (8). The results are expressed 
in titration units referring to a standard curve obtained by serial 
dilutions of a serum pool from 4-too-old MRL/MpJ-Ipr/lpr mice. 
To determine the allotype of anti-DNA antibodies,  an ELISA was 
performed using alkaline phosphatase-conjugated antiaUotype  an- 
tibodies. The results  are expressed  in titration units in reference 
to  a  standard  curve derived from  a  serum  pool of (NZW  x 
BXSB)F1 (Igh  "/b) male mice. 
The Ig allotype of anti-HGG antibodies raised during the course 
of the secondary immune response  was tested by an ELISA (11) 
using alkaline phosphatase-conjugated antiallotype antibodies. The 
results  are expressed in titration units in reference to a standard 
curve obtained from immunized (B6  x  BALB/c)F1 (Igh  a/b) mice. 
Statistical Analysis.  Statistical  analysis was performed with the 
Wilcoxon two-samples test. Probability values >5% were consid- 
ered insignificant. 
Results 
Generation of Yaa+-Yaa- BMC  Chimeras.  To investigate 
whether a possible unique interaction between B calls from 
mice bearing the Yaa gene and T  hdper cells is involved in 
the spontaneous production of autoantibodies, irradiated re- 
cipient  (NZW  x  B6)F1  mice  were  reconstituted  with  a 
mixture of BMC from autoimmune male mice bearing the 
Yaa  gene  (Igh  "/~ allotype)  and  female  or  male  mice  lack- 
ing the  Yaa gene (Igh  n/b aUotype), as described in Table 1 
(groups I and II). As control, irradiated B6 female mice were 
reconstituted with BMC from both BC20 (Igh ~) male and 
B6 (Igh  b) female mice (group III). 2 mo after reconstitution, 
the chimerism was checked by measuring serum levels of Ig 
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Figure 1.  Specificity  oflgh and IgG2a ailotype-specific  ELLS&.  Results 
(mean of %10) from 6-too-old mice are expressed as OD at 405 nm. 
1024  Mechanism  of Yaa Gene-induced Autoantibody Production Table  1.  BMC Chimeric Mice 
Group  BMC  donor  Recipient 
Male.Yaa  +  female ~  female 
(group  I) 
Male.Yaa  +  male ~  male 
(group  II) 
Male  +  female ~  female 
(group  III) 
(NZW  x  B6.Yaa)Pl  male (Igh  n/') 
+ 
(NZW  x  B6.Yaa)Pl  female (Igh  n/b) 
(NZW  x  B6.Yaa)F1 male (Igh  ~/~) 
+ 
(NZW  x  B6)F1 male (Igh  "/b) 
BC20  male  +  B6  female 
(NZW  x  B6.Yaa)F1 female (Igh  "/b) 
(NZW  x  B6)F~  male (Igh  n/b) 
B6  female 
Table  2.  Ig AllotH~e Levels in BMC Chimeric Mice 
Mice  Age  Igh  aUotype  Igh  '.n  Igh  b 
U  x  I0-3/ml 
Group I  2  a,  n,  b  3.6  _+  1.9  1.0  _+  0.4 
Group II  2  a,  n,  b  2.0  _+  1.4  0.7  _+  0.2 
Group  III  2  a, b  2.2  _+  1.1  1.3  _+  0.6 
(NZW  x  B6)FI male  6  n,  b  2.1  _+  1.0  1.2  +  0.3 
(NZW  x  B6.Yaa)F1 male  6  n,  b  10.0  _+  4.8  7.3  _+  3.1 
(NZW  x  B6.Yaa)F~ male  6  n,  a  25.2  +_  18.7  <0.01 
Serum levels of Igh  ~,n and Igh  b allotypes were measured in BMC chimeras (2 mo after reconstitution) and in 6-mo-old unmanipulated control mice 
by ELISA. Results are the mean of 10-20 mice _+  1 SD. 
allotypes.  Concentrations of Igh  ~,n allotypes detectable by 
the anti-Igh  ~ allotype assay were approximately three times 
higher than those of Igh  b allotype in groups I and II, as ex- 
pected (Table 2).  When IgG2a  ~ and IgG2a  b allotypes were 
specifically detected, their levels were comparable in group 
I  (IgG2aa:  4.1  _+  2.1  mg/ml;  IgG2ab:  3.2  _+  1.9 mg/ml; 
p  >  0.05)  and  in  group  II  (IgG2aa:  2.4  _+  0.7  mg/ml; 
IgG2ab:  2.7  +  1.6 mg/ml; p  >  0.1).  In mice of group III 
Group I  Group II  Group III 
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Figure 2.  Kinetics of serum levels of IgG (.4), Igh aUo- 
types (D-D), and IgG2a aUotypes (E-G) in BMC chimeras. 
Mean levels (10-20  mice in each group) of IgG in chi- 
meric mice (group I, 0; group II, O; group III, A) and 
control B6 mice (A) are expressed in mg/ml (A). Mean 
levels (_+  1 SD) of Igh and IgG2a anotypes (group I, B, 
E; group II, C and F; group III, D and G) are expressed 
in U/m1  x  10-3 and mg/ml, respectively. Statistical anal- 
ysis has shown that increases in Igh~.  n and IgG2a" allo- 
types (Yaa  + origin) at 4, 6, and 8 mo vs. at 2 mo in both 
groups I and II were significant (p < 0.001), while levels 
of the b allotype (Yaa- origin) did not significantly differ 
during the period of observation (p >  0.1). expressing both  Igh ~ and  Igh  b allotypes,  their  Ig allotype 
levels were essentially identical to those found in unmanipu- 
lated 6-too-old (NZW  x  B6)F1 Igh  n/b male mice. 
Kinetics of lgG Levels and Allotype Expression  in Yaa+-Yaa  - 
BMC Chimeras.  To study if chimeric mice developed hyper- 
gammaglobulinemia,  they were bled every 2 mo and serum 
levels of IgG were measured by ELISA. An age-dependent 
increase of IgG levels was observed in mice (groups I  and 
II) receiving a mixture of BMC from mice with and without 
the l~a gene (Fig. 2 A). In contrast, mice reconstituted with 
normal male and female BMC of B6 origin (group III) failed 
to develop hypergammaglobulinemia. 
In parallel to the elevation of total IgG levels, a selective 
age-related increase of the Igh ~,n allotype was observed in 
groups I and II, while the Igh  b allotype levels remained con- 
stant during the period of observation (up to 8 mo after the 
reconstitution)  (Fig.  2, B and C). The specific detection of 
IgG2a  aUotypes in  these  chimeras  again  revealed  an  age- 
dependent, selective increase of the IgG2a  a allotype in both 
group  I  (8  mo  post-reconstitution,  IgG2a~:  23.2  _+  9.9 
mg/ml)  and  group  II  (8 mo post-reconstitution,  IgG2a': 
13.4  _+  8.5 mg/ml)  (Fig.  2, E  and F).  In contrast,  IgG2a  b 
allotype levels remained detectable and unchanged during the 
whole study (8 mo post-reconstitution,  group I: 4.3  +  2.3 
mg/ml,  and group II: 3.6  +  1.4 mg/ml).  Notably, no in- 
crease in levels of both Ig allotypes was observed in mice of 
group III  (Fig.  2, D  and G). 
Selective Production of Anti-DNA  Antibodies by Yaa + Male 
B Cells.  The spontaneous production of IgG anti-DNA an- 
tibodies was examined in chimeric mice in comparison with 
unmanipulated  (NZW  x  B6.Yaa)F1 mice and normal con- 
trol mice. Serum levels of IgG anti-DNA progressively in- 
creased in both groups of mice reconstituted with a mixture 
of BMC from mice with and without the Yaa gene.  6 mo 
after cell transfer,  their titers were almost comparable to those 
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Figure 3.  Serum  levels  of IgG anti-DNA antibodies in BMC chimeras 
(6 mo after reconstitution) and 6-mo-old unmanipulated control mice. 
Results are expressed in U/ml. Group I, ~a cy +  9; group II, 1~a o" 
+  o'; group III, O'  +  9. 
found in 6-mo-old unmanipulated (NZW  x  B6.Yaa)F1 male 
mice (Fig.  3). In contrast,  no significant titers of IgG anti- 
DNA antibodies were detected in mice from group III,  as 
well as in (NZW  x  B6)Ft males, (NZW  x  B6.Yaa)F1 fe- 
males,  and control B6 females. 
The analysis  of the Ig allotype of anti-DNA  antibodies 
has shown that, as in the case of the hypergammaglobulinemia, 
anti-DNA  antibodies produced in mice of groups I  and II 
were exclusively of the  Igh  ',n  aUotype (Fig.  4),  indicating 
that  anti-DNA  antibodies  in  Yaa+-Yaa -  BMC  radiation 
chimeras were selectively produced by B cells from mice ex- 
pressing the Yaa gene. Notably, anti-DNA antibodies of both 
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Figure 4.  Serum  levels of Igh  ~.n (0) and Igh  b (O) anti- 
DNA antibodies in BMC chimeras (6 mo after reconsti- 
tution) and 6-mo-old  unmanipulated control mice. Results 
are expressed in U/ml. Group I, Yaa cy +  9; group II, 
Yaa O"  + 
1026  Mechanism  of ~,fia Gene-induced Autoantibody Production Table  3.  Ig Allotype Levels  of Total Ig,  Anti-HGG,  and Anti-DNA  Antibodies  in BMC Chimeric Mice 
Igh allotype*  Anti-HGG*  Anti-DNA* 
Group  Age  *  Igh  ~/n  Igh  b  Igh  "/"  lgh  b  Igh  ~/~  Igh  b 
U  x  lO-Vml  U/ml  U/ml 
Male.Yaa  +  female ~  female  2  9.1  +  3.4  1.4  +  0.3  1,579  +  702  618  _+  174  35  +  14  2  _+  1 
6  12.7  +  5.7  1.5  +_ 0.3  979  +_  575  394  -i-_ 166  72  +_  41  3 +  2 
(NZW  x  B6)F1 male  6  2.3  -+  1.2  1.8  _+  0.3  1,227 +  374  1,038 +  394  3  -+  1  3  +  1 
* 500 #g of AHGG was intraperitoneally  injected into Yaa + male--Yaa- female  chimeric  mice at 2 or 6 mo after  reconstitution  and 6-mo-old (NZW 
x  B6)F1 male mice. 2 mo later, mice were boosted with 500/~g of AHGG. The lg allotype  of anti-HGG antibodies was determined 10 d after 
challenge. Results are the mean of 5-10 mice •  1 SD. The titers of anti-HGG-specific  allotype  antibodies in nonimmunized  mice were <1 U/ml. 
Serum levels of Igh  ~,~ and Igh  b aUotypes and of anti-DNA allotypes  were measured by ELISA. 
allotypes were similarly detectable in unmanipulated (NZW 
x  B6.Yaa)F1  male (Igh  n/b) mice. 
Lack of Selective Production of Anti-HGG Antibodies by Yaa + 
B  Cells.  It has been previously suggested that B cells from 
BXSB male mice may be hyper-responsive  to appropriate T 
helper cell-mediated signals (12). To investigate if such a hyper- 
reactivity is responsible for the selective production of au- 
toantibodies by the Yaa + B cells in our double bone marrow 
chimeric mice, two groups of Yaa + male-Yaa-  female BMC 
chimeric mice were immunized with AHGG either at 2 or 
6 mo after the reconstitution and boosted 2 mo later.  If B 
calls of the Yaa + origin are indeed hypersensitive to T helper 
signals, we could expect in the anti-HGG immune response 
a distribution of the Ig  ~,n and Ig  b allotypes similar to that 
found for the total Ig allotype (6.5  times increase at 4 mo 
and 8.5 times at 8 mo) or for the anti-DNA antibodies (17.5 
times increase at 4 mo and 24 times at 8 mo). However, anti- 
HGG levels of the Igh  ~,n allotype in both groups of chimeric 
mice were only 2.5 times higher than those of the Ig  b allo- 
type (Table 3).  Notably, (NZW  x  B6)Ft male mice pro- 
duced both allotypes ofanti-HGG antibodies at a comparable 
level. This indicates that Yaa § B cells and Yaa-  B cells were 
activated in a similar fashion to produce anti-HGG antibodies 
in the double-chimeric mice, 
Discussion 
The BXSB Y chromosome-linked mutant gene, ￿89  ac- 
celerates the progression of a lupus-like autoimmune syndrome 
only in mice that are predisposed to autoimmune diseases. 
To better define the cellular mechanisms responsible for the 
Yaa gene effect, we have made BMC radiation chimeras con- 
taining two sets of B cells from mice with or without the 
Yaa gene, and the origin of anti-DNA autoantibodies was 
identified by using the Igh allotype marker. Our results have 
demonstrated that B cells from mice bearing the ~a gene 
were selectively activated in these chimeric mice to produce 
anti-DNA autoantibodies and hypergammaglobulinemia. 
The  analysis  of the  Igh  allotype in  Yaa+-Yaa -  BMC 
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chimeras has clearly shown that hypergammaglobulinemia 
and anti-DNA autoantibodies arose from the selective acti- 
vation of B cells from mice bearing the Yaa gene, but not 
from those lacking it. To explain this phenomenon, one may 
postulate a prevalent expansion of B  cells from the  ~a + 
mice, which results from the preferential repopulation of 
~a + lymphoid cell  lineages  over  the others  in  irradiated 
hosts. In fact, in the case of radiation chimeras  constructed 
with a mixture of BMC from mice with or without the Ipr 
gene, the Igh allotype of the donor lacking the lpr gene pro- 
gressively decreased from 2 mo post-transplantation and was 
barely detectable by 4-8 mo post-transplantation due to the 
selective repopulation by Ipr donor cells (13). However, the 
persistence  of Igh allotype of the l~a- donor at a constant 
level  and  the production  of anti-HGG antibodies by the 
Yaa-  B cells at a level comparable to that by Yaa + B cells 
rule out the selective elimination of the normal l~a- B cell 
population from our Yaa+-Yaa -  chimeras.  In addition, the 
implication of HY antigen-specific female T cells in the ob- 
served selective activation of the Yaa gene-bearing male B 
cells is unlikely because  of two reasons:  first,  the  ~a + B 
cells still produced autoantibodies in chimeras constructed 
with a mixture of male B cells with or without the Yaa gene, 
and second, normal male and female chimeras of B6 origin 
failed  to develop  an autoimmune syndrome. 
The fact that autoreactive B cells of the Yaa + origin are 
selectively  activated in  Yaa+-Yaa -  bone  marrow chimeric 
mice indicates that the l~a gene abnormality is likely to be 
expressed at least at the level orB cells. At present, the mech- 
anism leading to the selective activation of Yaa §  autoreac- 
tire B cells is unknown, but the following possible mecha- 
nism can be considered. 
First, the Yaa gene may cause an abnormality in B cells, 
which  renders  them  hyper-responsive  to  appropriate  T 
cell-mediated helper signals, due to abnormalities either in 
receptors for T helper factors or in regulatory molecules con- 
trolling cellular responsiveness  to appropriate signals.  The 
finding of Prud'homme et al. (12) may be relevant, showing 
the in vitro hyper-responsiveness  of male BXSB B cells to 
T helper signals, although this issue has never been addressed in the context of the Yaa gene expression. However, this first 
possibility appears to be less likely because of the absence of 
preferential production of anti-HGG antibodies by B cells 
of the Yaa + origin in Yaa +-Yaa- chimeric mice after immu- 
nization with AHGG. 
Second, the Yaa gene may be involved in the expression 
of  intercellular  adhesion  molecules  on  B  cells,  thereby 
facilitating their interaction with T helper cells. Again, results 
of anti-HGG responses argue against this possibility. 
Third, an attractive hypothesis is that the Yaa gene abnor- 
mality may be associated with the expression of an antigen 
on the surface of B cells, which can be directly or indirectly 
related to the Yaa gene, and its recognition by T helper cells 
could induce the activation of autoreactive Yaa + B cells. In 
fact, the recognition by T  helper cells of a self or modified 
Ia molecule expressed on B cells has been shown to be respon- 
sible for the development of a lupus-like autoimmune syn- 
drome observed during the course of chronic graft-vs.-host 
disease (14, 15), after induction of neonatal tolerance to al- 
loantigens (8, 16) or after injection of drugs or chemical agents 
(17,  18). In addition, such a possibility has been suggested 
to be involved in the initiation and/or progression of a lupus- 
like autoimmune disease (19).  The selective production of 
anti-DNA autoantibodies, but not antibodies to foreign an- 
tigens by Yaa + B cells in Yaa +-Yaa- chimeric mice, may well 
be explained by differences in the capacity of T  helper cells 
specific for DNA autoantigens and for HGG antigens to re- 
spond against their respective antigens. Because of the pres- 
ence of sui~cient anti-HGG-specific T cell help in Yaa +-Yaa- 
chimeric mice, as documented by the development of high 
and comparable titers of anti-HGG antibodies in both (NZW 
x  B6)F1 and  (NZW  x  B6.  Yaa)F1 male  mice (5),  the 
hypothetical ~a-specific T helper cells may not provide any 
additional help for anti-HGG responses. Consequently, there 
was no preferential production of anti-HGG antibodies by 
Yaa + B cells.  In contrast,  such Yaa-specific  T  helper cells 
may be essential for the promotion of anti-DNA autoim- 
mune responses in  (NZW  x  B6)F1 mice,  which have  a 
markedly limited activity of T  helper cells specific for anti- 
DNA autoimmune responses.  This hypothesis is consistent 
with our recent observations that BXSB male mice bearing 
the Yaa gene developed enhanced T cell-dependent antibody 
production to certain exogenous antigens, to which female 
BXSB mice mounted only limited immune responses (Fos- 
sati et al., manuscript in preparation).  In addition, our previous 
finding that male BXSB mice are able to develop T-dependent 
IgG anti-HGG responses in the absence of HGG-specific T 
helper cells, but the presence of non-HGG specific T helper 
cells (11), further supports the possible existence of Yaa-spedfic 
T helper cells in BXSB male mice. Clearly, the present demon- 
stration that the Yaa gene abnormality is expressed at the 
level of B cells would help to identify the molecular nature 
of the Yaa gene and to elucidate the molecular and cellular 
basis of the Yaa gene-induced acceleration of the autoimmune 
disease in BXSB  mice. 
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